Browse Related Topics For:

Hatch-Waxman

143
Pharmaceutical Industry
137
Patents
135
Generic Drugs
118
Pharmaceutical Patents
111
Patent Infringement
97
Patent Litigation
90
ANDA
79
Prescription Drugs
73
FDA
35
SCOTUS
33
FTC
33
FTC v Actavis
32
Reverse Payment Settlement Agreements
19
Pay-For-Delay
16
BPCIA
16
Mylan Pharmaceuticals
15
Patent-in-Suit
15
Personal Jurisdiction
14
Antitrust Litigation
14
Biosimilars
14
Inter Partes Review Proceedings
14
Popular
14
Teva Pharmaceuticals
12
Actavis Inc.
12
Sandoz
11
Patent Trial and Appeal Board
11
Watson Pharmaceuticals
9
America Invents Act
9
AstraZeneca
9
Safe Harbors
9
Settlement
8
Anti-Competitive
8
Apotex
8
Biologics
8
Prior Art
7
Appeals
7
Cephalon
7
Claim Construction
7
DaimlerChrysler v Bauman
7
Otsuka Pharmaceutical
7
Rule-of-Reason Analysis
6
Amgen
6
Declaratory Judgments
6
Eli Lilly
6
FDCA
6
Patent Applications
6
Preliminary Injunctions
6
Sandoz v Amgen
6
Sherman Act
6
USPTO
5
Classen Immunotherapies
5
Corporate Counsel
5
Endo Pharmaceuticals
5
FDA Approval
5
GlaxoSmithKline
5
Infringement
5
Merck
5
No-AG Agreement
5
Novartis
5
Obviousness
5
Orange Book
5
Patent Reform
5
Teva v Sandoz
4
Bayer
4
Federal Rule 12(b)(6)
4
Hospira
4
Induced Infringement
4
Jurisdiction
4
Labeling
4
Motion to Dismiss
4
Patent Dance
4
Patent Invalidity
4
Pleading Standards
4
Preemption
4
Standard of Review
4
Takeda Pharmaceuticals
4
Warner Chilcott
3
Allergan Inc
3
Biologics Price Competition and Innovation Act of 2009
3
Biotechnology
3
Class Action
3
Commercial Marketing
3
De Novo Standard of Review
3
Discovery
3
Disgorgement
3
Dismissals
3
Elan Pharmaceuticals
3
Healthcare
3
Hedge Funds
3
Innovation Act
3
Manufacturers
3
Minimum Contacts
3
Notice Requirements
3
Patent Trolls
3
Patent-Eligible Subject Matter
3
Product Hopping
3
Putative Class Actions
3
Reverse Payments
3
Specific Jurisdiction
3
Spectrum
3
Standing
3
Summary Judgment
3
Unfair Competition
2
aBLA
2
Amarin
2
Antitrust Provisions
2
Antitrust Violations
2
Article III
2
Biogen Idec
2
Broadest Reasonable Interpretation Standard
2
Burden of Proof
2
CA Supreme Court
2
Cartwright Act
2
DaimlerAG
2
Damages
2
Disclosure Requirements
2
Doctrine of Equivalents
2
Estoppel
2
Exclusivity
2
Failure To Warn
2
Forum Shopping
2
Generic
2
Genzyme
2
Injunctions
2
Innovation
2
Intellectual Property Litigation
2
Intellectual Property Protection
2
Licensing Rules
2
Life Sciences
2
Medicare Modernization Act
2
Monopolization
2
Motion To Stay
2
Mutual Pharmaceuticals v Bartlett
2
Non-Practicing Entities
2
Noninfringement
2
Orphan Drugs
2
Pfizer
2
PLIVA v Mensing
2
Presumption of Validity
2
Proposed Regulation
2
Shire Development v Watson
2
SmithKline Beecham
2
Subject Matter Jurisdiction
2
Validity
2
Written Descriptions
1
Abbott Laboratories
1
AbbVie
1
Abuse of Process
1
Affordable Care Act
1
Allergan v Sandoz
1
Amicus Briefs
1
AMP v Myriad
1
Annual Reports
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Injuries
1
Antitrust Standing
1
Attorney Disbarrment
1
Attorney-Client Privilege
1
Australia
1
Automatic Stay
1
Balancing Test
1
Bifurcation
1
Biofuel
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Bowman v Monsanto
1
Brand
1
Burden-Shifting
1
But For Causation
1
CAFA
1
Cancer
1
Certiorari
1
Chevron Deference
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
CLS Bank v Alice Corp
1
Coca Cola
1
Collateralized Debt Obligations
1
Combination Products
1
Comment Period
1
Competition
1
Compliance
1
Congressional Committees
1
Consent Order
1
Consideration
1
Contraceptives
1
Controlled Substances Act
1
Counterclaims
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
Cuozzo Speed Technologies
1
Cuozzo Speed Technologies v Lee
1
Dart Cherokee Basin Operating Co. v. Owens
1
Data Protection
1
DEA
1
Death Penalty
1
Dell
1
Design Defects
1
Design Patent
1
Direct Purchasers
1
Dirks v SEC
1
Discovery Schedule
1
DNA
1
Drug Approvals
1
Drug Compounding
1
Drug Safety
1
Duty to Deal
1
eBay
1
Emerging Markets
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
EPA
1
European Patent Office
1
Exemptions
1
Expert Testimony
1
Exports
1
Extrinsic Evidence
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Financial Crisis
1
Foreign Corporations
1
Foreign Defendants
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
Fraud
1
Fresenius
1
General Jurisdiction
1
Goodyear
1
Healthcare Costs
1
Hindsight Reconstruction
1
Human Genes
1
India
1
Injury-in-Fact
1
Innovator Liability
1
Insider Trading
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Internal Investigations
1
Inventions
1
ITC
1
Jazz Pharmaceuticals
1
Joinder
1
Justiciable Controversy
1
KBR (formerly Kellogg Brown & Root)
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Loss Causation
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Markman Hearing
1
Material Misrepresentation
1
Mayo v. Prometheus
1
Medical Devices
1
Medical Research
1
Misrepresentation
1
Monsanto
1
Morgan Stanley
1
Motion for Reconsideration
1
Motion to Amend
1
Myriad
1
New Trial
1
Nexium
1
Nintendo
1
Off-Label Use
1
Omissions
1
Omnicare v Laborers District Council
1
On-Sale Bar
1
Opioid
1
Out-of-State Companies
1
OxyContin
1
Par Pharmaceutical
1
Patent Agent Privilege
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-Misuse
1
Patentability Search
1
Pending Legislation
1
Permanent Injunctions
1
Personal Benefit
1
Petition For Rehearing
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Post-Grant Review
1
Premarket Approval Applications
1
Presidential Elections
1
Price Manipulation
1
Prilosec
1
Prioritized Examination
1
Privilege Waivers
1
Proctor & Gamble
1
Product Exclusivity
1
Product Labels
1
Professional Conferences
1
Prometheus
1
Proposed Amendments
1
Quality Control Plan
1
RanBaxy
1
Registration Requirement
1
Regulatory Agenda
1
Reissue Patents
1
Removal
1
Research and Development
1
Restraining Orders
1
Reversal
1
RICO
1
Ripeness
1
ROI
1
Roxane Laboratories
1
Royalties
1
Rule 26
1
Rulemaking Process
1
Sales Contracts
1
Scienter
1
Scope of Discovery Requests
1
Section 337
1
Settlements
1
Sham Litigation Exception
1
Single Occurrence
1
SNDAs
1
Standard of Proof
1
State Law Tort Claims
1
STRONG Patents Act
1
Supplemental Examination
1
Supply Chain
1
Tolling
1
Trademark Infringement
1
TRIPS Agreement
1
TRO
1
USDA
1
Vacated
1
Vaccinations
1
Valuation
1
Veterinarians
1
Veterinary Products
1
White Collar Crimes
1
WIPO
1
Work Product Privilege
1
World Intellectual Property Organisation
1
Young Lawyers